News Categories
Resources For Living
Mesothelioma Forum
Legal Help Blog
Find a Doctor Near You
About Mesothelioma
Latest News
- Iron Range Mesothelioma Health Screenings Underway...
- Mesothelioma Specialists Offer Optimal Care
- Chaplains Offer Comfort to Patients
- Mesothelioma Awareness Day - September 26
- Senator Edward “Ted” Kennedy: Cancer Advocate
- Mesothelioma Patients Sought for Clinical Trial
- Cancer Surgeons form Band to Benefit Cancer Resear...
- Progress in War on Cancer
- Wife Vows to Continue to Fight for Mesothelioma Cu...
- Earlier Detection of Mesothelioma Possible from Te...
News Archives
- April 2007
- May 2007
- June 2007
- July 2007
- August 2007
- September 2007
- October 2007
- November 2007
- December 2007
- January 2008
- February 2008
- March 2008
- April 2008
- May 2008
- June 2008
- July 2008
- August 2008
- September 2008
- October 2008
- November 2008
- December 2008
- January 2009
- February 2009
- March 2009
- April 2009
- May 2009
- June 2009
- July 2009
- August 2009
- September 2009
- October 2009
- November 2009
Tuesday, September 29, 2009
Eli Lilly and Co. announced this month that their drug Alimta has extended the life of lung cancer patients by about three months. The clinical trial findings were compared with patients who received the best treatment currently available and a placebo. The study was reported in The Lancet, a British medical journal.Alimta is approved for treatment in non-squamous tumors which is about 70 percent of all lung cancers. The patients, when treated with Alimta, lived for 15.5 months as compared to 10.3 months for the patients receiving a placebo. Alimta is also approved as a treatment for mesothelioma.
Alimta is used as "maintenance therapy" on patients who have previously received chemotherapy and whose cancer has not progressed. The clinical trial was conducted on a group of 663 patients.
Alimta Findings
Labels: mesothelioma, Treatment News
posted by Nancy Meredith at 4:15 PM
